DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award
About
Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Patient-Centered Outcomes and Survivorship Award (PCOSA) promotes evidence-based and patient-centered approaches to improve health and lung cancer related outcomes and enhance the patient experience in defined populations. Research must address at least one of the FY26 LCRP areas of emphasis in the Health Outcomes and Survivorship category. Distinctive Features: • This funding mechanism requires the research team to include an advocate who is a lung cancer patient/survivor or caregiver. • This funding mechanism allows proposed projects to include translational or clinical research, including pilot clinical trials.
The DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award (PCOSA) is designed for researchers and clinical teams committed to advancing lung cancer care through patient-centered approaches. This grant funds evidence-based research that improves health outcomes, enhances survivorship experiences, and prioritizes patient perspectives in defined populations. The award supports translational and clinical research, including pilot clinical trials that address specific FY26 Lung Cancer Research Program areas of emphasis in health outcomes and survivorship. What makes this funding opportunity distinctive is its requirement for research teams to include a lung cancer patient, survivor, or caregiver as an advocate—ensuring that real-world patient experiences directly inform research direction and outcomes. Researchers, academic institutions, medical centers, and clinical research organizations should apply if they are developing interventions or studies that meaningfully improve quality of life, treatment outcomes, or survivorship support for lung cancer patients. This is an excellent opportunity for teams seeking to bridge the gap between clinical research and patient-centered care while securing dedicated funding to bring these innovations to life. Applications are accepted through the Department of Defense Lung Cancer Research Program with a deadline of September 2, 2026.
Funding Facts
● Applications openDeadline
September 2, 2026
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Varies by cycle
Deadline
2026-09-02
Grant Type
federal
Application Cycle
Annual
Best For
Research institutions, academic medical centers, and clinical research teams focused on patient-centered lung cancer outcomes and survivorship
Frequently Asked Questions
Who is eligible for the DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award?
Eligibility criteria for this award vary and may depend on institutional affiliation, researcher qualifications, and team composition. The key requirement is that research teams must include an advocate who is a lung cancer patient, survivor, or caregiver. For complete eligibility requirements and institutional eligibility information, visit the official Department of Defense Lung Cancer Research Program website or consult the full FY26 PCOSA funding announcement.
How much funding does the DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award provide?
Specific funding amounts for the FY26 PCOSA cycle have not been publicly detailed in available materials. Funding varies by fiscal year and program cycle. For current award amounts and budget guidelines, applicants should consult the official DoD LCRP funding announcement or contact the program directly.
How do I apply for the DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award?
Applications are submitted through the Department of Defense's standard grant submission process. The deadline for the FY26 cycle is September 2, 2026. Applicants should prepare a research proposal that addresses at least one FY26 LCRP area of emphasis in health outcomes and survivorship, and include documentation of their patient/survivor/caregiver advocate team member. Visit the official Department of Defense Lung Cancer Research Program website for application instructions, required forms, and detailed submission guidelines.
What can DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award funding be used for?
This award funds evidence-based, patient-centered research aimed at improving lung cancer-related health outcomes and enhancing the patient experience. Supported research includes translational research, clinical research, and pilot clinical trials that align with FY26 LCRP health outcomes and survivorship emphasis areas. Projects must incorporate patient or caregiver perspectives throughout the research design and implementation. For specific allowable expenses and research focus areas, review the full FY26 funding announcement on the Department of Defense Lung Cancer Research Program website.
Last updated: July 5, 2026